IL1B and epidermolysis bullosa: Therefore, therapeutic approaches that inhibit the IL-1β signaling pathway may be beneficial for patients with EB and EB simplex by reducing cellular inflammation and stabilizing the intermediate filament network after thermal shock [79,80].